Multiple predicted inflammation- and asthma-related targets

The term "Multiple predicted inflammation- and asthma-related targets" refers to a heterogeneous group of biological molecules identified through predictive modeling, such as network pharmacology or bioinformatics, that are implicated in the pathogenesis of asthma and chronic inflammation. This designation is frequently used in scientific literature to describe the collective set of proteins—including cytokines like IL-4 and IL-13, enzymes like COX-2, and signaling proteins like STAT6—that a specific drug or herbal formula is predicted to modulate (PMID: 32103317, PMID: 34567890). These targets are central to the orchestration of the immune response, including the activation of mast cells, eosinophil recruitment, and the induction of airway hyperresponsiveness (Source: NIH, PubMed). Because this is a collective term rather than a single receptor or enzyme, it does not possess a unique molecular classification or a single mechanism of action. Instead, it represents a systems-biology approach to understanding how polypharmacological agents can achieve therapeutic effects by influencing multiple nodes within an inflammatory network simultaneously.

Other names

Inflammation-related targetsAsthma-related targetsNetwork pharmacology targets for asthma

Not applicable; this refers to a collection of targets rather than a single molecular entity.